A Prospective Cohort Study for Long COVID and Health Outcomes in Older Adults in Yunnan, China
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 11,527
- 试验地点
- 1
- 主要终点
- Incidence of long COVID
研究概览
简要总结
The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohort study carried out in Anning, Yunnan. The primary aim of this study is to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.
详细描述
COVID-19 pandemic attributed to a great number of mortalities around the world in the last 3 years. About 46% of the global population are estimated to have been infected by the omicron variant and its sublineages. Health outcomes post COVID-19 has been of great concern globally since more and more people infected by SARS-CoV-2. Integrated efforts should be made to estimate the incidence of reinfections and long COVID in China, especially among older adults who are vunlerable and susceptible to COVID-19. In view of this, the Peking University Health Cohort Study in Anning, Yunnan aims to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Resided in Anning in the past half year and have no plan to move out in next 1 year
- •Older adults who are willing to participate in this study with informed consent
排除标准
- •Unable to answer questions or communicate
- •Older adults who are not willing to participate in this study or without informed consent
结局指标
主要结局
Incidence of long COVID
时间窗: From baseline until the date of long COVID symptoms or date of death from any cause, whichever came first, assessed up to 12 months.
The proportion of participants incurred any symptoms or diagnosed diseases of post-COVID in all infected participants.
次要结局
- Reinfection incidence of COVID-19(At 3 months, 6 months, 9 months, 1 year after baseline investigation.)
- Incidence of catastrophic health expenditure(At 3 months, 6 months, 9 months, 1 year after baseline investigation.)
- Cognitive impairment(At 3 months, 6 months, 9 months, 1 year after baseline investigation.)
- Sleep quality(At 3 months, 6 months, 9 months, 1 year after baseline investigation.)
- Depression(At 3 months, 6 months, 9 months, 1 year after baseline investigation.)
- Medical expenditure(At 3 months, 6 months, 9 months, 1 year after baseline investigation.)
研究者
Liu Jue
Prof.
Peking University